Bespak in talks with potential acquirer:
This article was originally published in Clinica
Executive Summary
UK drug delivery device manufacturer Bespak today revealed it is in "very preliminary" discussions with an unnamed party over a potential takeover bid for the company. The news gave a boost to the UK firm's shares, which have taken a tumble over recent months following disappointing sales of its Exubera insulin inhaler (see Clinica No 1265, p 13). Nomura Code analyst Charles Weston suggested that Bespak's potential suitors could include other medical device plastics manufacturer, who could generate significant cost synergies, or leveraged buy-out firms, who could use the company's strong free cash flow generation to "heavily gear the balance sheet".
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.